INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 146 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,035,114 | -12.6% | 180,300 | +7.4% | 0.00% | 0.0% |
| Q1 2024 | $4,618,929 | -8.6% | 167,900 | +1.3% | 0.00% | -25.0% |
| Q4 2023 | $5,052,193 | -8.4% | 165,700 | -5.0% | 0.00% | 0.0% |
| Q3 2023 | $5,514,528 | -21.6% | 174,400 | +1.1% | 0.00% | -20.0% |
| Q2 2023 | $7,034,550 | +23.5% | 172,500 | +12.9% | 0.01% | +25.0% |
| Q1 2023 | $5,694,856 | -1.2% | 152,800 | -7.5% | 0.00% | 0.0% |
| Q4 2022 | $5,763,828 | -36.4% | 165,200 | +2.0% | 0.00% | -33.3% |
| Q3 2022 | $9,060,000 | +10.9% | 161,900 | +2.6% | 0.01% | 0.0% |
| Q2 2022 | $8,168,000 | -29.0% | 157,800 | -0.4% | 0.01% | 0.0% |
| Q1 2022 | $11,511,000 | -33.1% | 158,400 | +8.9% | 0.01% | -40.0% |
| Q4 2021 | $17,204,000 | -5.4% | 145,500 | +7.3% | 0.01% | -16.7% |
| Q3 2021 | $18,191,000 | -16.4% | 135,600 | +0.9% | 0.01% | -7.7% |
| Q2 2021 | $21,761,000 | +151.0% | 134,400 | +24.4% | 0.01% | +116.7% |
| Q1 2021 | $8,668,000 | +50.0% | 108,000 | +1.7% | 0.01% | +50.0% |
| Q4 2020 | $5,777,000 | +181.8% | 106,200 | +3.0% | 0.00% | +100.0% |
| Q3 2020 | $2,050,000 | -4.0% | 103,100 | +1.5% | 0.00% | 0.0% |
| Q2 2020 | $2,136,000 | +166.7% | 101,600 | +55.1% | 0.00% | +100.0% |
| Q1 2020 | $801,000 | -16.6% | 65,500 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $961,000 | +20.0% | 65,500 | +9.2% | 0.00% | 0.0% |
| Q3 2019 | $801,000 | -16.9% | 60,000 | +1.9% | 0.00% | 0.0% |
| Q2 2019 | $964,000 | +32.8% | 58,900 | +38.6% | 0.00% | 0.0% |
| Q1 2019 | $726,000 | +25.2% | 42,500 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $580,000 | -52.3% | 42,500 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $1,216,000 | +4.6% | 42,500 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,163,000 | +44.3% | 42,500 | +11.3% | 0.00% | 0.0% |
| Q1 2018 | $806,000 | +5.6% | 38,200 | -3.8% | 0.00% | 0.0% |
| Q4 2017 | $763,000 | +48.4% | 39,700 | +91.8% | 0.00% | 0.0% |
| Q3 2017 | $514,000 | +55.3% | 20,700 | 0.0% | 0.00% | – |
| Q2 2017 | $331,000 | +13.4% | 20,700 | 0.0% | 0.00% | – |
| Q1 2017 | $292,000 | +7.7% | 20,700 | 0.0% | 0.00% | – |
| Q4 2016 | $271,000 | – | 20,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 1,859,926 | $301,141,000 | 48.58% |
| Burrage Capital Management LLC | 63,634 | $10,303,000 | 10.33% |
| Elmwood Wealth Management, Inc. | 67,174 | $10,876,000 | 5.73% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 300,327 | $48,626,000 | 4.72% |
| Discovery Value Fund | 929,669 | $150,523,000 | 4.08% |
| Ikarian Capital, LLC | 294,400 | $47,667,000 | 3.85% |
| Ally Bridge Group (NY) LLC | 93,127 | $15,078,000 | 3.75% |
| GREAT POINT PARTNERS LLC | 100,000 | $16,191,000 | 3.40% |
| ARK Investment Management | 7,684,441 | $1,244,188,000 | 2.32% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $18,043,000 | 2.30% |